179 related articles for article (PubMed ID: 38533566)
41.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
42. The role of
Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
[TBL] [Abstract][Full Text] [Related]
43.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
44. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
45.
Martin-Gallausiaux C; Salesse L; Garcia-Weber D; Marinelli L; Beguet-Crespel F; Brochard V; Le Gléau C; Jamet A; Doré J; Blottière HM; Arrieumerlou C; Lapaque N
Gut Microbes; 2024; 16(1):2295384. PubMed ID: 38126163
[TBL] [Abstract][Full Text] [Related]
46. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
47. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
48. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
[TBL] [Abstract][Full Text] [Related]
49. Tubeimuside I improves the efficacy of a therapeutic
Tong Y; Lu G; Wang Z; Hao S; Zhang G; Sun H
Front Immunol; 2023; 14():1154818. PubMed ID: 37207216
[TBL] [Abstract][Full Text] [Related]
50. A newly developed PCR-based method revealed distinct Fusobacterium nucleatum subspecies infection patterns in colorectal cancer.
Bi D; Zhu Y; Gao Y; Li H; Zhu X; Wei R; Xie R; Wei Q; Qin H
Microb Biotechnol; 2021 Sep; 14(5):2176-2186. PubMed ID: 34309194
[TBL] [Abstract][Full Text] [Related]
51. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
[TBL] [Abstract][Full Text] [Related]
52. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
[TBL] [Abstract][Full Text] [Related]
53.
Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
[TBL] [Abstract][Full Text] [Related]
54. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
55. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
56. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
[TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers.
Chen Y; Lu Y; Ke Y; Li Y
Medicine (Baltimore); 2019 Sep; 98(39):e17221. PubMed ID: 31574832
[TBL] [Abstract][Full Text] [Related]
58. Modulation of Intratumoral
Qu X; Yin F; Pei M; Chen Q; Zhang Y; Lu S; Zhang X; Liu Z; Li X; Chen H; Zhang Y; Qin H
ACS Nano; 2023 Jun; 17(12):11466-11480. PubMed ID: 37201179
[TBL] [Abstract][Full Text] [Related]
59. Both endogenous and exogenous miR-139-5p inhibit Fusobacterium nucleatum-related colorectal cancer development.
Zhao Y; Tao Q; Li S; Zheng P; Liu J; Liang X
Eur J Pharmacol; 2020 Dec; 888():173459. PubMed ID: 32768506
[TBL] [Abstract][Full Text] [Related]
60. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]